Intrinsic Value

The intrinsic value of Revenio Group Oyj (REVXF) under the Base Case is 6.0683 USD per share. Compared with the current market price of 13.5442 USD, the stock appears Overvalued by 55% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

REVXF Intrinsic Value
$6.0683
Overvaluation 55%
Intrinsic Value
Price $13.5442
R

REVXF is cheaper than usual. Still overvalued, but less so than on 95% of days in the past 5 years.

Monitor REVXF
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value $4.85
Get notified when the price drops into your buy zone
Current Price $13.54
Intrinsic Value $6.07
Margin of Safety 20% $4.85
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to REVXF

Fundamental Analysis

What Revenio Group Oyj Does

Health Care

Revenio Group Oyj is a medical technology company best known for devices and software used to screen and monitor eye disease, especially glaucoma and other conditions that can damage vision. It also makes tools for bone health assessment. The company sells mainly to eye clinics, hospitals, screening programs, and other healthcare providers that need reliable diagnostic equipment.

Headquarters
Finland FI
Employees
246
IPO date
Jan 1, 2003
Read the full company overview
View Company Overview

Latest Earnings Call

Q2 2026 · September 8, 2026

Open the earnings call
EPS
€0.05
Expected
€0.11
Surprise
−54.5%
Stock, day of the call
0.0%
View Earnings Call
Financials
Efficiency

Earnings Waterfall
Revenio Group Oyj

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one REVXF stock?

The intrinsic value for Revenio Group Oyj (REVXF) under the Base Case is 6.0683 USD.

Is REVXF stock undervalued or overvalued?

Compared with the current market price of 13.5442 USD, the stock appears Overvalued by 55% .

Back to Top